Researchers take first steps toward a vaccine for pancreatic cancer

by Chris Mahony,Queen Mary, University of LondonCredit: CC0 Public DomainResearchers from Queen Mary University of London and Zhengzhou University have developed a personalized vaccine system th

Updated on: June 24,2024

Researchers take first steps toward a vaccine for pancreatic cancer

by Chris Mahony,Queen Mary, University of LondonCredit: CC0 Public DomainResearchers from Queen Mary University of London and Zhengzhou University have developed a personalized vaccine system th

Updated on:June 24,2024

Blood cancer research points to new treatment for bone marrow cancer

byUniversity of VirginiaDeletion of IL-1R1 preferentially inhibits Jak2V617F mutant hematopoietic stem/progenitor cells.aA scheme on competitive BM transplantation approach to assess

Updated on: January 15,2024

Blood cancer research points to new treatment for bone marrow cancer

byUniversity of VirginiaDeletion of IL-1R1 preferentially inhibits Jak2V617F mutant hematopoietic stem/progenitor cells.aA scheme on competitive BM transplantation approach to assess

Updated on:January 15,2024

Percentage of breast cancer survivors in Canada doubles over past 15 years, study finds

by Jelena Damjanovic,University of Toronto(A) Distribution of breast cancer survivors by current (2022) age group. (B) Prevalence of net survivors of breast cancer within Canadian population by

Updated on: January 23,2024

Percentage of breast cancer survivors in Canada doubles over past 15 years, study finds

by Jelena Damjanovic,University of Toronto(A) Distribution of breast cancer survivors by current (2022) age group. (B) Prevalence of net survivors of breast cancer within Canadian population by

Updated on:January 23,2024

Study shows potential for new radiopharmaceutical cancer treatment

by Elizabeth Chapin,University of KentuckyGastrin- releasing peptide receptor (GRPR) immunoreactivity in uterine cervix cancer. Hematoxylin and eosin (H&E) staining of uterine cervix cancer

Updated on: February 20,2024

Study shows potential for new radiopharmaceutical cancer treatment

by Elizabeth Chapin,University of KentuckyGastrin- releasing peptide receptor (GRPR) immunoreactivity in uterine cervix cancer. Hematoxylin and eosin (H&E) staining of uterine cervix cancer

Updated on:February 20,2024

Study links gut microbiome and aggressive prostate cancer

by Cleveland ClinicCredit: CC0 Public DomainCleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, su

Updated on: April 20,2024

Study links gut microbiome and aggressive prostate cancer

by Cleveland ClinicCredit: CC0 Public DomainCleveland Clinic researchers have shown for the first time that diet-associated molecules in the gut are associated with aggressive prostate cancer, su

Updated on:April 20,2024

Researchers find a new promising therapeutic target for glioblastoma

by Spanish National Research CouncilGliobastoma (astrocytoma) WHO grade IV—MRI coronal view, post contrast. 15 year old boy. Credit: Christaras A/ Wikipedia.Glioblastoma is the most frequent and aggre

Updated on: June 19,2024

Researchers find a new promising therapeutic target for glioblastoma

by Spanish National Research CouncilGliobastoma (astrocytoma) WHO grade IV—MRI coronal view, post contrast. 15 year old boy. Credit: Christaras A/ Wikipedia.Glioblastoma is the most frequent and aggre

Updated on:June 19,2024

Clinical trial shows efficacy for atezolizumab combined with carboplatin

byVanderbilt University Medical CenterCredit: CC0 Public DomainImmunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastati

Updated on: January 26,2024

Clinical trial shows efficacy for atezolizumab combined with carboplatin

byVanderbilt University Medical CenterCredit: CC0 Public DomainImmunotherapy in combination with chemotherapy has become an important therapeutic treatment option in some patients with metastati

Updated on:January 26,2024

Survival of children with acute lymphatic leukemia has increased to 94%, study finds

by Princess Máxima Center for Pediatric OncologyCredit: Unsplash/CC0 Public DomainThe five-year survival of all children with acute lymphatic leukemia (ALL) has continued to increase to 94%. This is e

Updated on: January 23,2024

Survival of children with acute lymphatic leukemia has increased to 94%, study finds

by Princess Máxima Center for Pediatric OncologyCredit: Unsplash/CC0 Public DomainThe five-year survival of all children with acute lymphatic leukemia (ALL) has continued to increase to 94%. This is e

Updated on:January 23,2024

Study shows how to make (and destroy) a metastatic cancer cell

by CU Anschutz Medical CampusColorado study shows that inhibiting the lysosomal stage of autophagy (and not necessarily the action of the autophagosome) may kill metastatic cancer cells. Credit:

Updated on: May 31,2024

Study shows how to make (and destroy) a metastatic cancer cell

by CU Anschutz Medical CampusColorado study shows that inhibiting the lysosomal stage of autophagy (and not necessarily the action of the autophagosome) may kill metastatic cancer cells. Credit:

Updated on:May 31,2024

Researchers identify promising drug to treat gastrointestinal cancers

by Joe Dangor,Mayo ClinicCredit: Unsplash/CC0 Public DomainGastrointestinal cancers are some of the most commonly diagnosed cancers, and they continue to be associated with poor survival outcome

Updated on: April 07,2024

Researchers identify promising drug to treat gastrointestinal cancers

by Joe Dangor,Mayo ClinicCredit: Unsplash/CC0 Public DomainGastrointestinal cancers are some of the most commonly diagnosed cancers, and they continue to be associated with poor survival outcome

Updated on:April 07,2024

Novel drug combination shows promise for advanced HER2-negative breast cancer

by Johns Hopkins University School of MedicineClinical efficacy.a–c, Responses as shown by a waterfall plot (a), swimmers plot (b) and spider plot (c). The dashed lines correspond to +20% a

Updated on: May 09,2024

Novel drug combination shows promise for advanced HER2-negative breast cancer

by Johns Hopkins University School of MedicineClinical efficacy.a–c, Responses as shown by a waterfall plot (a), swimmers plot (b) and spider plot (c). The dashed lines correspond to +20% a

Updated on:May 09,2024

Researchers describe a new resistance mechanism

by IDIBELL-Bellvitge Biomedical Research InstituteDue to the treatment with the antibody against Semaphorin 4D (anti-Sema4D), changes occur in the tumor vasculature as well as a decrease in tumor

Updated on: June 08,2024

Researchers describe a new resistance mechanism

by IDIBELL-Bellvitge Biomedical Research InstituteDue to the treatment with the antibody against Semaphorin 4D (anti-Sema4D), changes occur in the tumor vasculature as well as a decrease in tumor

Updated on:June 08,2024